Cellular and molecular characterization of abnormal brain development in protein O-mannose N-acetylglucosaminyltransferase 1 knockout mice

Methods in Enzymology

Volumn 479, Issue C, 2010, Pages 353-366

  Liu, Jianmin ^a   Yang, Yuan ^b   Li, Xiaofeng ^c   Zhang, Peng ^d   Qi, Yue ^e   Hu, Huaiyu ^d  

^a VICAM   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; GLIAL FIBRILLARY ACIDIC PROTEIN; LAMININ; MANNOSE; MESSENGER RNA; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN O MANNOSE N ACETYLGLUCOSAMINYLTRANSFERASE 1; UNCLASSIFIED DRUG;

BASEMENT MEMBRANE; BINDING AFFINITY; BOOK; BRAIN DEVELOPMENT; CATALYSIS; EXON; EYE DEVELOPMENT; FERTILITY; FIBROBLAST; GLYCOSYLATION; KNOCKOUT MOUSE; LIFESPAN; MOUSE; MUSCLE DEVELOPMENT; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING;

MUS;

EID: 77956194828     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)79020-0     Document Type: Chapter

References (23)

1. Biancheri R., Bertini E., Falace A., Pedemonte M., Rossi A., D'Amico A., Scapolan S., Bergamino L., Petrini S., Cassandrini D., Broda P., Manfredi M., et al. POMGnT1 mutations in congenital muscular dystrophy genotype-phenotype correlation and expanded clinical spectrum. Arch. Neurol. 2006, 63:1491-1495.
2. Brancaccio A. An adhesion molecule involved in muscular dystrophies: structural and functional analysis of dystroglycan domains. Ital. J. Biochem. 2003, 52:51-54.
3. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995, 80:675-679.
4. Chiyonobu T., Sasaki J., Nagai Y., Takeda S., Funakoshi H., Nakamura T., Sugimoto T., Toda T. Effects of fukutin deficiency in the developing mouse brain. Neuromuscul. Disord. 2005, 15:416-426.
5. Clement E.M., Godfrey C., Tan J., Brockington M., Torelli S., Feng L., Brown S.C., Jimenez-Mallebrera C., Sewry C.A., Longman C., Mein R., Abbs S., et al. Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch. Neurol. 2008, 65:137-141.
6. Durbeej M., Henry M.D., Campbell K.P. Dystroglycan in development and disease. Curr. Opin. Cell Biol. 1998, 10:594-601.
7. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 1993, 122:809-823.
8. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
9. Grewal P.K., Holzfeind P.J., Bittner R.E., Hewitt J.E. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet. 2001, 28:151-154.
10. Hehr U., Uyanik G., Gross C., Walter M.C., Bohring A., Cohen M., Oehl-Jaschkowitz B., Bird L.M., Shamdeen G.M., Bogdahn U., Schuierer G., Topaloglu H., et al. Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease. Neurogenetics 2007, 8:279-288.
11. Hu H., Yang Y., Eade A., Xiong Y., Qi Y. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease. J. Comp. Neurol. 2007, 502:168-183.
12. Liu J., Ball S.L., Yang Y., Mei P., Zhang L., Shi H., Kaminski H.J., Lemmon V.P., Hu H. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech. Dev. 2006, 123:228-240.
13. Longman C., Brockington M., Torelli S., Jimenez-Mallebrera C., Kennedy C., Khalil N., Feng L., Saran R.K., Voit T., Merlini L., Sewry C.A., Brown S.C., Muntoni F. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet. 2003, 12:2853-2861.
14. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H., Straub V., Mathews K.D., Moore S.A., Campbell K.P. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002, 418:417-422.
15. Michele D.E., Campbell K.P. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 2003, 278:15457-15460.
16. Miyagoe-Suzuki Y., Masubuchi N., Miyamoto K., Wada M.R., Yuasa S., Saito F., Matsumura K., Kanesaki H., Kudo A., Manya H., Endo T., Takeda S. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech. Dev. 2009, 126:107-116.
17. Montanaro F., Carbonetto S. Targeting dystroglycan in the brain. Neuron 2003, 37:193-196.
18. Oliveira J., Soares-Silva I., Fokkema I., Gonçalves A., Cabral A., Diogo L., Galán L., Guimarães A., Fineza I., den Dunnen J.T., Santos R. Novel synonymous substitution in POMGNT1 promotes exon skipping in a patient with congenital muscular dystrophy. J. Hum. Genet. 2008, 53:565-572.
19. Sato S., Omori Y., Katoh K., Kondo M., Kanagawa M., Miyata K., Funabiki K., Koyasu T., Kajimura N., Miyoshi T., Sawai H., Kobayashi K., et al. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat. Neurosci. 2008, 11:923-931.
20. Takahashi S., Sasaki T., Manya H., Chiba Y., Yoshida A., Mizuno M., Ishida H., Ito F., Inazu T., Kotani N., Takasaki S., Takeuchi M., et al. A new beta-1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology 2001, 11:37-45.
21. Taniguchi K., Kobayashi K., Saito K., Yamanouchi H., Ohnuma A., Hayashi Y.K., Manya H., Jin D.K., Lee M., Parano E., Falsaperla R., Pavone P., et al. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum. Mol. Genet. 2003, 12:527-534.
22. Yang Y., Zhang P., Xiong Y., Li X., Qi Y., Hu H. Ectopia of meningeal fibroblasts and reactive gliosis in the cerebral cortex of the mouse model of muscle-eye-brain disease. J. Comp. Neurol. 2007, 505:459-477.
23. Yoshida A., Kobayashi K., Manya H., Taniguchi K., Kano H., Mizuno M., Inazu T., Mitsuhashi H., Takahashi S., Takeuchi M., Herrmann R., Straub V., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell. 2001, 1:717-724.